Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-04-30

Mediators of Inflammatory in Asthma

Objectif



Asthma is a complex inflammatory disease driven by a network of inflammatory mediators, including lipid mediators, cytokines, neuropeptides and nitric oxide. The mechanisms of increased mediator production in asthma are not well understood. Our primary objective is to elucidate the mechanisms involved in increased mediator production in asthma in order to understand the pathophysiology of this increasingly common condition and to lead to the development of new and more specific therapies. We have adopted a multi-disciplinary molecule-to-man approach as the questions and scope of the research is complex and needs to involve several groups. We have brought together leading European research groups in the field of inflammatory mediators to address this objective.
Major research tasks include elucidation of the factors that regulate expression of lipid mediators (leukotrienes, prostaglandins and platelet-activating factor) and their receptors in airway and inflammatory cells, experimental models of asthma and in normal and asthmatic airways. We will also study regulation of expression of lymphokines and chemokines that orchestrate eosinophilic inflammation in asthmatic airways, sensory neuropeptides and their receptors and the enzyme that generates nitric oxide, using the same approaches.
Establishment of a network of investigators will allow us to study the interactions between different mediators, by taking advantage of the different assays and technologies available amongst the partners. A unifying theme to this project is the idea that there are common molecular mechanisms leading to increased expression of the genes responsible for the synthesis and effects (receptors) of multiple inflammatory mediators. For example, pro-inflammatory cytokines increase the expression of enzymes involved in the arachidonic acid cascade. We will investigate the role of common transcription factors, such as nuclear factor-kappa B and activator protein-l that are activated by various cytokines, in regulating the increased expression of inflammatory mediators and their receptors in asthmatic airways.
The long-term objectives of our project are to develop more specific therapies to control and prevent the inflammation of asthma. This can only be achieved by greater understanding of the molecular basis for asthmatic inflammation. This requires a critical mass of investigators, with a multiplicity of experimental approaches, ranging from molecular biology through to clinical studies of asthmatic patients. This concerted action provides an opportunity to exploit the highly esteemed European research on inflammatory mediators in order to advance our knowledge more rapidly, and to make inroads into the important health and social problems created by asthma within the European Union.

Champ scientifique (EuroSciVoc)

CORDIS classe les projets avec EuroSciVoc, une taxonomie multilingue des domaines scientifiques, grâce à un processus semi-automatique basé sur des techniques TLN. Voir: Le vocabulaire scientifique européen.

Vous devez vous identifier ou vous inscrire pour utiliser cette fonction

Programme(s)

Programmes de financement pluriannuels qui définissent les priorités de l’UE en matière de recherche et d’innovation.

Thème(s)

Les appels à propositions sont divisés en thèmes. Un thème définit un sujet ou un domaine spécifique dans le cadre duquel les candidats peuvent soumettre des propositions. La description d’un thème comprend sa portée spécifique et l’impact attendu du projet financé.

Appel à propositions

Procédure par laquelle les candidats sont invités à soumettre des propositions de projet en vue de bénéficier d’un financement de l’UE.

Données non disponibles

Régime de financement

Régime de financement (ou «type d’action») à l’intérieur d’un programme présentant des caractéristiques communes. Le régime de financement précise le champ d’application de ce qui est financé, le taux de remboursement, les critères d’évaluation spécifiques pour bénéficier du financement et les formes simplifiées de couverture des coûts, telles que les montants forfaitaires.

CSC - Cost-sharing contracts

Coordinateur

Imperial College of Science Technology and Medicine
Contribution de l’UE
Aucune donnée
Adresse
Dovehouse Street
SW3 6LY London
Royaume-Uni

Voir sur la carte

Coût total

Les coûts totaux encourus par l’organisation concernée pour participer au projet, y compris les coûts directs et indirects. Ce montant est un sous-ensemble du budget global du projet.

Aucune donnée
Mon livret 0 0